Advances in Hematological Malignancies
Recent centuries have witnessed remarkable progress in the domain of hematological malignancies. Novel therapies such as targeted drugs, immunotherapies, and gene editing are revolutionizing the outlook for patients with blood cancers. Research studies continue to explore these innovative approaches, offering potential for more effective treatment